Author

Jun Luo

Johns Hopkins UniversityORCID 0000-0002-1414-473XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jun Luo3 papers · Army Medical University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Abhishek ShettyiD· 1 shared Adrianna Amaral· 1 shared Channing Judith PalleriD· 1 shared Deven TopiwalaiD· 1 shared Emirhan TekogluiD· 1 shared Eugene ShenderoviD· 1 shared Ezra G. BarabaniD· 1 shared Huong P. T. NguyeniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek ShettyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyThe FASEB JournalPeer-reviewedJan 28, 2025

CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty…·Sushant K. Kachhap

This study shows CRM1 regulates androgen receptor stability and DNA repair in prostate cancer, suggesting combination therapy with CRM1 and DNA repair inhibitors could be effective.

2 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 21, 2025

B7-H3 as a Dual Clinically Relevant Checkpoint and Antibody Drug Conjugate Target Expressed Across Adenocarcinoma and Neuroendocrine Prostate Cancers

Shivang Sharma, Nikita Mundhara, Emirhan Tekoglu…·Eugene Shenderov

This paper evaluates B7-H3 expression across prostate cancer subtypes and identifies it as a stable target for ADC and ICI due to its low heterogeneity and negative regulation by androgen signaling.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky